EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dipna Pharmachem's enterprise value is ₹252 Mil.
Dipna Pharmachem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34 Mil. Therefore, Dipna Pharmachem's EV-to-EBITDA for today is 7.33.
The historical rank and industry rank for Dipna Pharmachem's EV-to-EBITDA or its related term are showing as below:
BOM:543594'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.33 Med: 11.52 Max: 21.92
Current: 7.33
During the past 5 years, the highest EV-to-EBITDA of Dipna Pharmachem was 21.92. The lowest was 7.33. And the median was 11.52.
BOM:543594's EV-to-EBITDA is ranked better than 76.55% of 469
companies
in the Healthcare Providers & Services industry
Industry Median: 12.48
vs BOM:543594: 7.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Dipna Pharmachem EV-to-EBITDA Historical Data
The historical data trend for Dipna Pharmachem's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dipna Pharmachem's EV-to-EBITDA
For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dipna Pharmachem's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dipna Pharmachem's EV-to-EBITDA falls into.
Dipna Pharmachem's current Enterprise Value is ₹252 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dipna Pharmachem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Dipna Pharmachem's PE Ratio for today is calculated as:
Dipna Pharmachem's share price for today is ₹8.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dipna Pharmachem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.609.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Dipna Pharmachem's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Dipna Pharmachem (BOM:543594) Business Description
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543594 has been successfully added to your